Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More
Novel Dual Chamber Dispenser with polycarbonate and stainless steel components for accurate Rx dosing. More
Aerosolized pharmaceutical composition with low potential toxicity, significantly reducing airway inflammation and remodelling More
The University of Edinburgh has perfected a genetic engineering strategy in mouse embryonic stem cells to replace large regions of mouse chromosomal sequences (>100kb) with the corresponding human syntenic region. More
Adjuvant that induces a potent antigen-specific CD8 cytotoxic T-cell response with long lasting immunity More
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes More
L-histidine is being developed as a prescription drug and as a dietary supplement for 1) chronic inflammatory gastrointestinal diseases; 2) conjunctivitis and seasonal allergic rhinitis; 3) infectious and non-infectious diarrheas; and 4) as an antioxidant More
The University of Edinburgh has developed a new method of screening for polymorphs and solvates of drug compounds that has potential to revolutionise the way polymorph screening is conducted. More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us